Twin Cities Business magazine has named Sofia Fund CEO, Cathy Connett to its 2021 list of Notable Leaders in Private Equity, Investment Banking and Venture Capital List in their Dec/Jan issue.…
Sofia Fund
Sofia Fund Partner Joy Lindsay Recognized for Lifetime Achievement as Technology Investor
MINNNEAPOLIS (Nov. 17, 2021) – Sofia Fund, the angel investment firm focused exclusively on women-led companies, announces that its partner, long-term investor Joy Lindsay, has received the Lifetime Achievement Award for an outstanding career in technology from the Minnesota Technology Association (MnTech).…
Cognition Therapeutics Adds Public Company Financial and Operational Expertise to Board of Directors with Appointment of Ellen B. Richstone
PURCHASE, N.Y., Nov. 03, 2021 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina (the “Company” or “Cognition”), today announced the addition of Ellen B.…
Sofia Fund Portfolio Earns Returns as Two Portfolio Companies Move to Next Stage of Growth
Cognitive Therapeutics goes public, Explorer Surgical acquired
MINNEAPOLIS (Oct. 25, 2021) – Sofia Fund, the angel investment firm focused exclusively on women-led companies, announces new milestones: two of its portfolio companies have progressed onto their next stages of growth, providing returns for Sofia’s group of investors.…
Sofia portfolio company Cognition Therapeutics goes public
Women-led biopharmaceutical company Cognition Therapeutics newly public stock started trading Oct. 8. CGTX (new NASDAQ ticker) innovates therapeutics that target age-related degenerative diseases and disorders. See the news here: https://ir.cogrx.com/news-releases/news-release-details/cognition-therapeutics-announces-pricing-upsized-initial-public…
Neurology Clinic Will Use Oculogica’s EyeBox to Detect Concussions in Patients
Sofia Fund portfolio company Oculogica signs on one of the largest neurology clinics in the U.S. to use its device.
Oculogica has been awarded a US patent to detect CTE via its eye tracking technology
This is a major innovation as CTE (chronic traumatic encephalopathy) is currently only diagnosed after death.
Joylux announces new expanded products to support women through menopause
In partnership with Dr. Sarah de la Torre, Ob-Gyn and functional medicine expert, Joylux has designed science-based products, digital tools, and relevant information to help women thrive during this phase of their life.
Oculogica Adds to IP Portfolio with Patent for Assessment of Impairment Due to Cannabis
Oculogica’s patent enables expansion of its eye-tracking based technology to fulfill an unmet need in cannabis impairment detection
Oculogica Receives Department of Defense Grant to Develop Wearable Concussion Diagnostic with Pre-eminent Partners
Sofia Fund portfolio company Oculogica receives $2M U.S. Army grant to develop wearable version of its technology
Keller Army Hospital at West Point, Children’s Hospital of Philadelphia, University of Wisconsin-Green Bay and AdHawk Microsystems will work with Oculogica to develop the wearable diagnostic.…